Ignite Creation Date:
2024-05-06 @ 4:33 PM
Last Modification Date:
2024-10-26 @ 2:12 PM
Study NCT ID:
NCT05027373
Status:
UNKNOWN
Last Update Posted:
2021-08-30
First Post:
2021-08-17
Brief Title:
Safety Tolerability and Pharmacokinetic of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection
Sponsor:
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
Organization:
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
Organization Data
Organization:
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
Class:
INDUSTRY
Study ID:
SSGJ-613-HH-I-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None